National Immunobiological Company (Nacimbio) – is a pharmaceutical holding Company founded on October 29, 2013 by Rostec State Corporation. Nacimbio is engaged in development, production and sales of immunobiologicals such as vaccines, blood derived products, bacteriophages, allergens etc. Its product portfolio includes over 220 items.  

Its mission is to facilitate the development of Russian immunobiological enterprises and ensure national sovereignty in the production and supply of immunobiological medicines, not produced in the Russian Federation, which poses a threat to national security in healthcare. Nacimbio holds two major Russian producers of immunobiologicals – Microgen and Fort (10 production sites overall).



Panel discussion 14:40 – 16:40

Questions and topics for discussion:
● Issues relating to the organization of the aseptic manufacturing of biological products

With the support of General partner company - National Immunobiological Company” (Nacimbio)